AISAP Cardio vs Zio AT ECG Monitoring System
AI Verdict
Choose AISAP Cardio if…
Choose AISAP Cardio if you require rapid, AI-powered point-of-care ultrasound diagnostics for immediate assessment of structural heart disease or heart failure at the patient's bedside. This tool is ideal for quickly obtaining comprehensive cardiac measurements and interpretations to guide urgent clinical decisions.
View AISAP Cardio →Choose Zio AT ECG Monitoring System if…
Choose Zio AT ECG Monitoring System if you need continuous, long-term ECG monitoring to detect intermittent or asymptomatic arrhythmias over an extended period, up to 14 days. This wearable solution is best suited for remote patient monitoring and capturing elusive cardiac events that may not be present during a brief in-office examination.
View Zio AT ECG Monitoring System →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AISAP Cardio | Zio AT ECG Monitoring System |
|---|---|---|
| Pricing | Unknown | Contact for pricing |
| Deployment | Cloud-based | Cloud-based (data analytics and clinician portal) |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Zio AT ECG Monitoring SystemWhile AISAP Cardio streamlines POCUS for clinicians, Zio AT offers a comprehensive and highly patient-centric usability experience with its comfortable wearable patch, patient mobile app for symptom logging, and a clinician portal for easy management and report interpretation. The high patient compliance and preference over traditional Holter monitors highlight its superior usability for both patients and providers in its specific use case.
Clinical Value
TieBoth tools demonstrate significant and validated clinical value in their respective domains. AISAP Cardio excels in rapid, accurate point-of-care diagnosis of structural heart disease and heart failure, empowering a broader range of clinicians. Zio AT provides superior long-term, continuous arrhythmia detection compared to traditional methods, leading to higher diagnostic yields and changes in patient management. Their distinct clinical applications are both highly impactful.
Pricing & Value
Zio AT ECG Monitoring SystemWhile both tools lack public pricing, Zio AT provides more transparency around its service fee model, insurance coverage, and patient financial assistance programs, which adds tangible value and accessibility for patients and providers. The clear CPT codes and reimbursement information, despite past fluctuations, offer a more defined financial pathway.
Enterprise Readiness
Zio AT ECG Monitoring SystemTool B explicitly states HIPAA compliance and the availability of a Business Associate Agreement (BAA), which are crucial for enterprise adoption in healthcare. While Tool A emphasizes integration and scalability, the explicit compliance statements from Tool B provide greater assurance for large-scale deployment and data handling.
Innovation
TieBoth tools are highly innovative, applying AI to different critical aspects of cardiac care. AISAP Cardio pioneers AI-powered POCUS for comprehensive structural heart disease diagnosis at the bedside, enabling non-cardiologists. Zio AT innovates with its long-term wearable, continuous monitoring, and deep-learned AI for superior arrhythmia detection, transforming remote cardiac diagnostics. Both represent significant advancements in their respective fields.
Support & Docs
Zio AT ECG Monitoring SystemTool B offers more explicit and comprehensive support channels, including 24/7 phone and email support for both patients and providers, along with dedicated resources for billing and patient education. While Tool A provides contact information and a member portal, Tool B's round-the-clock availability and broader resource offerings indicate a more robust support infrastructure.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AISAP Cardio | Zio AT ECG Monitoring System |
|---|---|---|
| Name | AISAP Cardio | Zio AT ECG Monitoring System |
| Company | Aisap | iRhythm Technologies, Inc. |
| Primary Function/Category | AI-powered point-of-care ultrasound (POCUS) software for cardiac diagnostic assessments | Wearable mobile cardiac telemetry (MCT) service for continuous, AI-powered ECG monitoring |
| Specialties | Cardiology, Emergency Medicine, Radiology | Cardiology |
| Key AI-powered Capability | AI-powered interpretation for early cardiac disease detection, automated generation of analyses, interpretations, and reports | FDA-cleared deep-learned AI algorithm (ZEUS System) for arrhythmia detection |
| Specific Measurements/Monitoring | Assessment of valvular pathologies (mitral, tricuspid, aortic regurgitation, aortic stenosis), Measurement of Left Ventricle Ejection Fraction (LVEF), right and left ventricular dimensions, atrial areas, ascending aorta diameter, and IVC diameter | Continuous, uninterrupted ECG recording for up to 14 days, detection of symptomatic and asymptomatic cardiac events |
Videos
Demos, reviews, and walkthroughs featuring AISAP Cardio and Zio AT ECG Monitoring System.
Frequently Asked Questions
More Comparisons
More matchups featuring AISAP Cardio or Zio AT ECG Monitoring System
Backers
Who funded each tool's parent company.